OSE.PA
Price:
$6.98
Market Cap:
$152.68M
OSE Immunotherapeutics SA focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. Its products include Tedopi that is in Phase III clinical stage for the treatment of non-small cell lung cancer, as well as in Phase II clinical trial to pancreatic and ovarian cancer; CoVepiT, a prophylactic vaccine against the SARS-CoV-2 virus; BI 765063, which is in Phase I clinical trial to treat solid tumors; and BiCKI, a novel bispecific checkpoint inhibitor platform, targeting PD-1 and innovative targets to fight primary and secondary resistance mechanisms developed by cancers. The company's products also comprise OSE-12...[Read more]
Industry
Biotechnology
IPO Date
2015-03-30
Stock Exchange
EURONEXT
Ticker
OSE.PA
According to OSE Immunotherapeutics SA’s latest financial reports and current stock price. The company's current ROE is 88.29%. This represents a change of -542.80% compared to the average of -19.94% of the last 4 quarters.
The mean historical ROE of OSE Immunotherapeutics SA over the last ten years is 11.07%. The current 88.29% ROE has changed 697.94% with respect to the historical average. Over the past ten years (40 quarters), OSE.PA's ROE was at its highest in in the December 2014 quarter at 271.48%. The ROE was at its lowest in in the June 2023 quarter at -52.64%.
Average
11.07%
Median
-22.99%
Minimum
-100.80%
Maximum
353.05%
Discovering the peaks and valleys of OSE Immunotherapeutics SA ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.12%
Maximum Annual ROE = 353.05%
Minimum Annual Increase = -189.46%
Minimum Annual ROE = -100.80%
Year | ROE | Change |
---|---|---|
2023 | -100.80% | 84.72% |
2022 | -54.57% | 53.94% |
2021 | -35.45% | 31.12% |
2020 | -27.03% | 239.92% |
2019 | -7.95% | -189.46% |
2018 | 8.89% | -146.93% |
2017 | -18.94% | -159.14% |
2016 | 32.03% | -183.03% |
2015 | -38.57% | -110.93% |
2014 | 353.05% | 1.12% |
The current ROE of OSE Immunotherapeutics SA (OSE.PA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-63.60%
5-year avg
-45.16%
10-year avg
11.07%
OSE Immunotherapeutics SA’s ROE is greater than Innate Pharma S.A. (-84.39%), less than Quantum Genomics SA (1.40%), greater than Valneva SE (-4.23%), less than Poxel S.A. (104.21%), less than Nanobiotix S.A. (283.43%),
Company | ROE | Market cap |
---|---|---|
-84.39% | $161.25M | |
1.40% | $5.00M | |
-4.23% | $544.03M | |
104.21% | $11.28M | |
283.43% | $183.26M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OSE Immunotherapeutics SA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like OSE Immunotherapeutics SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is OSE Immunotherapeutics SA's ROE?
How is the ROE calculated for OSE Immunotherapeutics SA (OSE.PA)?
What is the highest ROE for OSE Immunotherapeutics SA (OSE.PA)?
What is the 3-year average ROE for OSE Immunotherapeutics SA (OSE.PA)?
What is the 5-year average ROE for OSE Immunotherapeutics SA (OSE.PA)?
How does the current ROE for OSE Immunotherapeutics SA (OSE.PA) compare to its historical average?